SCHEDULE 13D/A Filed 2026-07-21 Event 2026-07-16 SEC 0001346824-26-000197 →

RA CAPITAL MANAGEMENT, L.P. → VOR BIOPHARMA INC. VOR

Stake: — Shares: 12,937,855 Class: Common Stock, par value $0.0001 per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

2 transactions

0 buys · 2 sales · 0 awards/exercises

Issuer Cluster

4 13D/G filings on this issuer

3 other filings besides this one

Filer Track Record

76 filings by this filer

75 other filings in the data moat

Short Interest · settle 2026-06-30

DTC 3.76

7,743,558 shares short · +30.1% vs prior

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-04-20	RA CAPITAL MANAGEMENT, L.P.	director, 10%+ owner	Sale	171,963	$15.77	$2.71M
2026-04-17	RA CAPITAL MANAGEMENT, L.P.	director, 10%+ owner	Sale	458,411	$16.28	$7.46M

Other 13D/G Filings on VOR BIOPHARMA INC.

Filed	Form	Filer	Stake	Shares
2025-10-10	SCHEDULE	Reprogrammed Interchange LLC	20.10%	1,374,775	view →
2023-08-11	SC	RA CAPITAL MANAGEMENT, L.P.	—	—	view →
2022-11-14	SC	RA CAPITAL MANAGEMENT, L.P.	—	—	view →

Other Filings by RA CAPITAL MANAGEMENT, L.P.

Filed	Form	Issuer	Stake	Shares
2026-07-20	SCHEDULE 13G	Agenus Inc.	—	—	view →
2026-07-07	SCHEDULE 13D/A	Climb Bio, Inc. CLYM	33.00%	23,249,186	view →
2026-07-02	SCHEDULE 13D/A	WEREWOLF THERAPEUTICS, INC. HOWL	4.10%	1,985,541	view →
2026-06-26	SCHEDULE 13D/A	WEREWOLF THERAPEUTICS, INC. HOWL	6.00%	2,915,742	view →
2026-06-24	SCHEDULE 13D/A	SOLID BIOSCIENCES INC. SLDB	—	12,036,126	view →
2026-06-22	SCHEDULE 13D/A	WEREWOLF THERAPEUTICS, INC. HOWL	—	3,654,307	view →
2026-06-18	SCHEDULE 13D	Parabilis Medicines, Inc. PBLS	23.80%	28,933,371	view →
2026-06-15	SCHEDULE 13D/A	ARTIVA BIOTHERAPEUTICS, INC. ARTV	36.60%	17,811,623	view →
2026-06-15	SCHEDULE 13D/A	WEREWOLF THERAPEUTICS, INC. HOWL	—	5,138,703	view →
2026-06-03	SCHEDULE 13G	Editas Medicine, Inc. EDIT	—	—	view →
2026-05-21	SCHEDULE 13G	Sana Biotechnology, Inc. SANA	—	—	view →
2026-05-14	SCHEDULE 13D/A	WEREWOLF THERAPEUTICS, INC. HOWL	—	6,116,140	view →
2026-05-13	SCHEDULE 13D/A	ARTIVA BIOTHERAPEUTICS, INC. ARTV	—	16,377,468	view →
2026-01-09	SCHEDULE	Cidara Therapeutics, Inc.	—	—	view →
2025-11-07	SCHEDULE	LENZ Therapeutics, Inc. LENZ	13.60%	4,265,106	view →
2025-11-07	SCHEDULE	Sionna Therapeutics, Inc. SION	22.60%	10,071,712	view →
2025-11-03	SCHEDULE	89bio, Inc.	—	—	view →
2025-10-01	SCHEDULE	ARS Pharmaceuticals, Inc. SPRY	11.10%	10,940,977	view →
2025-09-30	SCHEDULE	PepGen Inc. PEPG	29.20%	20,099,753	view →
2025-08-11	SCHEDULE	Cidara Therapeutics, Inc.	13.30%	3,365,523	view →

Showing 20 of 75

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →